Clinical course and approaches to therapy in kidney transplant recipients with the novel COVID-19 disease
The COVID-19 pandemic has had global consequences due to the wide spread of the infection in the world, lack of currently proven effective therapy, resistance to treatment in a significant proportion of those affected and, as a result, high mortality, especially among high-risk groups. Kidney transp...
Main Authors: | O. N. Kotenko, L. Yu. Artyukhina, N. F. Frolova, E. S. Stolyarevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2021-01-01
|
Series: | Vestnik Transplantologii i Iskusstvennyh Organov |
Subjects: | |
Online Access: | https://journal.transpl.ru/vtio/article/view/1265 |
Similar Items
-
RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01) -
Predicting the outcome of COVID-19 infection in kidney transplant recipients
by: Ozgur Akin Oto, et al.
Published: (2021-03-01) -
A family cluster of diagnosed coronavirus disease 2019 (COVID‐19) kidney transplant recipient in Thailand
by: Parichart Sakulkonkij, et al.
Published: (2020-12-01) -
The impact of comorbidities on clinical course and outcome, in kidney transplant recipients with COVID-19: A systematic review and analysis
by: Amit Bansal, et al.
Published: (2020-01-01) -
TRADITIONAL AND CASCADE PLASMAPHERESIS IN ANTIBODY TITERS’ REDUCTION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)